Page last updated: 2024-09-05

sorafenib and tolvaptan

sorafenib has been researched along with tolvaptan in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(tolvaptan)
Trials
(tolvaptan)
Recent Studies (post-2010) (tolvaptan)
6,5207305,251967172786

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)tolvaptan (IC50)
Bile salt export pumpHomo sapiens (human)9.99
Vasopressin V2 receptorHomo sapiens (human)0.1486
Vasopressin V1a receptorHomo sapiens (human)0.351

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Sas, KM1

Reviews

1 review(s) available for sorafenib and tolvaptan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for sorafenib and tolvaptan

ArticleYear
Targeting B-Raf as a treatment strategy for polycystic kidney disease.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:5

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Benzenesulfonates; Cell Proliferation; Cells, Cultured; Humans; Niacinamide; Phenylurea Compounds; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridines; Sorafenib; Tolvaptan

2010